October 9, 2025
Leah Christoforidis was pregnant with her fourth child when she began feeling pain in her lower back. What her doctor initially figured was a muscle tear, was actually a rare type of kidney cancer called translocation renal cell carcinoma (tRCC).
Searching for answers, she visited Dana-Farber, where she found caring experts and a new purpose through an initiative called Count Me In.
Like a mill crumbling into a river, solid tumors constantly shed bits of themselves — including their DNA — into the bloodstream. This free-floating genetic material, known as circulating tumor DNA (ctDNA), contains a trove of information that can help guide cancer research and treatment. Learn more.
Breast cancer is one of the most common forms of cancer in the United States. The good news: early detection increases the chances of successful treatment. Learn about the different screening methods available and current recommendations.
Dana-Farber’s basic science laboratories are at the forefront of discovering biological mechanisms that drive new therapeutic advances. Recent findings suggest that viral vectors can be engineered to adjust when and where viral DNA integrates, paving the way for safer and more precise tools for gene therapy.
Make an Appointment or Contact Us
Contact Dana-Farber
Adult: 877-442-3324 Pediatric: 888-733-4662
Other Inquiries >
Feedback
© Dana-Farber Cancer Institute
450 Brookline Avenue, Boston, 02215
dana-farber.org
Manage your preferences | Opt Out using TrueRemove™ Got this as a forward? Sign up to receive our future emails. View this email online.
450 Brookline Ave. | Boston, MA 02215 US
This email was sent to [email protected]. To continue receiving our emails, add us to your address book.
